World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
54
Citations
28074
World Ranking
2293
National Ranking
1130

Sandra Orsulic publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Sandra Orsulic sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 144 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Sandra Orsulic D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Sandra Orsulic sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 54 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Sandra Orsulic is affiliated with the University of California, Los Angeles in the United States. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with specific focus on Molecular Biology, Oncology, Reproductive Medicine, Immunology, and Cancer Research.

Their work covers multiple key topics in cancer research, including:

  • Ovarian cancer diagnosis and treatment
  • Cancer Immunotherapy and Biomarkers
  • PARP inhibition in cancer therapy
  • Cancer Cells and Metastasis
  • Immune cells in cancer
  • Cancer, Lipids, and Metabolism
  • DNA Repair Mechanisms

Recent publications by Sandra Orsulic include:

  • "Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment," 2021, Nature Communications
  • "Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer," 2020, Cell Death and Disease
  • "Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids," 2022, Proceedings of the National Academy of Sciences
  • "Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors," 2020, EMBO Molecular Medicine
  • "Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas," 2024, Nature Communications

The venues where Sandra Orsulic most frequently publishes include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Gynecologic Oncology
  • Cancer Research
  • Nature Communications
  • Frontiers in Oncology

Sandra Orsulic frequently collaborates with the following researchers:

  • Beth Y. Karlan
  • Ann E. Walts
  • María Sol Recouvreux
  • Jenny Lester
  • David G. Huntsman

Best Publications

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

  • Integrated genomic characterization of endometrial carcinoma

    Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander

  • The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

    Stephan Gasser;Sandra Orsulic;Eric J. Brown;David H. Raulet

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation

    Sandra Orsulic;Otmar Huber;Hermann Aberle;Sebastian Arnold

  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

    Ashton C Berger;Anil Korkut;Rupa S Kanchi;Apurva M Hegde

  • Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

    Shan Deng;Shan Deng;Xiaojun Yang;Xiaojun Yang;Heini Lassus;Shun-Zhi Liang

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Mouse Models of Cancer

    Dong-Joo Cheon;Sandra Orsulic

  • Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

    Sandra Orsulic;Yi Li;Robert A. Soslow;Lynn A. Vitale-Cross

  • An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling.

    Sandra Orsulic;Mark Peifer

  • A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer

    Dong-Joo Cheon;Yunguang Tong;Myung-Shin Sim;Judy Dering

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Negative regulation of Armadillo, a Wingless effector in Drosophila

    Li Mei Pai;Sandra Orsulic;Amy Bejsovec;Mark Peifer

  • Dose-Response Association of CD8(+) Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    Ellen L. Goode;Matthew S. Block;Kimberly R. Kalli;Robert A. Vierkant

  • Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

    Chad A Hall;Runsheng Wang;Jiangyong Miao;Esther Oliva

  • CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer

    Elda Righi;Satoshi Kashiwagi;Jianping Yuan;Michael Santosuosso

  • A role for the Drosophila segment polarity gene armadillo in cell adhesion and cytoskeletal integrity during oogenesis

    Mark Peifer;Sandra Orsulic;Dari Sweeton;Eric Wieschaus

  • Development of a flexible and specific gene delivery system for production of murine tumor models.

    Galen H Fisher;Sandra Orsulic;Eric Holland;Wendy P Hively

  • ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

    Ellen L. Hedditch;Bo Gao;Amanda J. Russell;Yi Lu

Frequent Co-Authors

Beth Y. Karlan
Beth Y. Karlan University of California, Los Angeles
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Susan J. Ramus
Susan J. Ramus University of New South Wales
Graham G. Giles
Graham G. Giles University of Melbourne
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Ian G. Campbell
Ian G. Campbell Peter MacCallum Cancer Centre
Andrew Berchuck
Andrew Berchuck Duke University
Marc T. Goodman
Marc T. Goodman Cedars-Sinai Medical Center
Douglas A. Levine
Douglas A. Levine New York University
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Molecular Biology often explore diverse online degree and career advancement opportunities in health sciences. For those considering a career in Speech-Language Pathology, there are asha accredited slp programs available online that meet the strict standards of the American Speech-Language-Hearing Association. These programs ensure you receive recognized training, whether you’re starting your journey or seeking career progression.

If your bachelor’s degree is outside communication sciences, online bridge programs non-SLP majors can help you transition into this field. These flexible pathways are designed to open doors for non-traditional students and career changers.

In nursing, many prospective students look for online absn programs for non nurses to quickly become registered nurses, leveraging science backgrounds like molecular biology. Accelerated programs help fast-track your entry into healthcare roles.

For those considering advanced practice, the psych np salary varies across states and is a key factor in career planning. This role blends science with patient care, offering both professional growth and competitive compensation.

Best Scientists Citing Sandra Orsulic

Trending Scientists

Recently Published Articles